Selected article for: "disease severity and patient presentation"
Author: Akoluk, Arda; Mazahir, Usman; Douedi, Steven; Aziz, Adel; Obagi, Aref; Kiss, Daniel; Flynn, Daniel; Costanzo, Eric; Simsir, Sinan A; Saybolt, Matthew D
Title: Pulmonary Embolism in COVID-19 Treated with VA-ECLS and Catheter tPA
  • Cord-id: g1mfkrz2
  • Document date: 2020_9_3
    • ID: g1mfkrz2
    Snippet: BACKGROUND: Novel coronavirus 2019 (COVID-19) has been the focus of the medical world since being declared a pandemic in March 2020. While the pathogenesis and heterogeneity of COVID-19 manifestations is still not fully understood, viral evasion of cellular immune responses and inflammatory dysregulation are believed to play essential roles in disease progression and severity. CASE PRESENTATION: We present the first case of a patient with COVID-19 with massive pulmonary embolism treated successf
    Document: BACKGROUND: Novel coronavirus 2019 (COVID-19) has been the focus of the medical world since being declared a pandemic in March 2020. While the pathogenesis and heterogeneity of COVID-19 manifestations is still not fully understood, viral evasion of cellular immune responses and inflammatory dysregulation are believed to play essential roles in disease progression and severity. CASE PRESENTATION: We present the first case of a patient with COVID-19 with massive pulmonary embolism treated successfully with systemic thrombolysis, VA-ECLS, and bail out catheter directed thrombolysis. He was discharged from the hospital after an eventful hospital course on therapeutic anticoagulation with warfarin. CONCLUSIONS: We present the first case of a patient with COVID-19 with massive pulmonary embolism (PE) treated successfully with systemic thrombolysis, VA-ECLS and bail out catheter directed thrombolysis. In our experience catheter directed thrombolysis comes with an acceptable bleeding risk despite use of mechanical circulatory support, particularly with meticulous attention to vascular access and dose response monitoring.

    Search related documents:
    Co phrase search for related documents
    • access vascular and acute ards respiratory distress syndrome: 1, 2
    • access vascular and low molecular: 1
    • access vascular and low molecular weight: 1
    • access vascular and low molecular weight heparin: 1
    • active infection and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • active infection and admission prior: 1, 2, 3
    • active infection and low molecular: 1, 2, 3
    • active infection and low molecular weight: 1, 2
    • active infection and low molecular weight heparin: 1, 2
    • acute ards respiratory distress syndrome and admission prior: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and low molecular: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute ards respiratory distress syndrome and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute ards respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute pulmonary embolism and admission prior: 1, 2, 3
    • acute pulmonary embolism and low molecular: 1, 2, 3, 4, 5, 6
    • acute pulmonary embolism and low molecular weight: 1, 2, 3, 4, 5, 6
    • acute pulmonary embolism and low molecular weight heparin: 1, 2, 3, 4, 5
    • adjunctive heparin and low molecular weight: 1
    • adjunctive heparin and low molecular weight heparin: 1